This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sangamo BioSciences Inc (SGMO)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 39.54M 45.87M 24.13M 21.66M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 39.54M 45.87M 24.13M 21.66M
Selling, General, and Administrative Expenses 19.20M 15.68M 13.80M 12.14M
Research & Development 67.20M 56.74M 36.98M 31.71M
Operating Income before D & A (EBITDA) -46.86M -26.55M -26.65M -22.20M
Depreciation & Amortization 1.81M 1.65M 1.48M 1.55M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 431.00K 134.00K 22.00K -66.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -48.24M -28.06M -28.11M -23.81M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -48.24M -28.06M -28.11M -23.81M
Income Taxes -5.72M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -40.70M -26.42M -26.62M -22.26M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -40.70M -26.42M -26.62M -22.26M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -40.70M -26.42M -26.62M -22.26M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-40.70M -26.42M -26.62M -22.26M
Preferred Dividends
Net Income Available To Common -40.70M -26.42M -26.62M -22.26M
Basic EPS from Continuing Ops. -0.58 -0.39 -0.48 -0.42
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.58 -0.39 -0.48 -0.42
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.58 -0.39 -0.48 -0.42
Basic Normalized Net Income/Share -0.58 -0.39 -0.48 -0.42
EPS fr Continuing Ops. -0.58 -0.39 -0.48 -0.42
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.58 -0.39 -0.48 -0.42
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.58 -0.39 -0.48 -0.42
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.58 -0.39 -0.48 -0.42
Dividends Paid per Share 0.00 0.00 0.00 0.00
SGMO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

SGMO Sangamo BioSciences Inc

Chart of SGMO

Analysts Ratings for SGMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 8 8 8
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SGMO ANALYST REPORT

SGMO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs